By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Manufacturing, marketing, and sales of its patented and Food and Drug Administration (FDA) cleared7.49M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States56.29M100.00%